๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease
NCT06608355Early-onset Parkinson's Disease
iRegene Therapeutics Co., Ltd.
Phase 1
6
Wuhan
2024-08-23
Recruiting
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
NCT06647901Giant Cell Tumor of Bone
Tang Xiaodong
Phase 1/2
45
Beijing
2024-08-23
Recruiting
DPA-714 and FDG PET/MRI in Depression
NCT06565936Depression
The First Affiliated Hospital of Dalian Medical University
Not applicable
70
Dalian
2024-08-23
Recruiting
Comparison of Stent-Related Symptoms Between Anti-Reflux Stents and Standard DJ Stents in Children With Urolithiasis
NCT06569173Urolithiasis, Child, Only
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
108
Hangzhou
2024-08-23
Recruiting
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer
NCT06340230HR Positive/HER2 Low Breast Cancer
Shengjing Hospital
Phase 2
93
Shenyang
2024-08-23
Active, closed
A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease
NCT06610526Chronic Kidney Disease
AstraZeneca
Phase 4
731
Beijing, Changchun, Dongguan, Foshan, Fuyang, Fuzhou, Ganzhou, Harbin
2024-08-23
By invitation
A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
NCT06863831Esophageal Squamous Cell Carcinoma (ESCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
536
Beijing
2024-08-22
Recruiting
9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
NCT06592326Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3
460
Shanghai
2024-08-22
Recruiting
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
NCT04974138Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcyโ‰ฅ10ยตmol/L), Insufficient Plasma Folate Levels (<12ng/mL)
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4
32,000
Bengbu, Bozhou, Chizhou, Fuyang, Beijing, Yangjiang, Guiyang, Huaihua
2024-08-22
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
NCT06535607Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
AstraZeneca
Phase 2
257
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan
2024-08-22
Active, closed
A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus
NCT06530849Refractory Systemic Lupus Erythematosus
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1/2
20
Shanghai, Wuhan
2024-08-22
By invitation
Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
NCT06712017Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable
GrandPharma (China) Co., Ltd.
Observational
100
Guangzhou, Jinan, Xiโ€™an, Beijing, Shanghai
2024-08-22
Recruiting
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
NCT04974151Hypertension, MTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4
24,000
Bengbu, Bozhou, Chizhou, Fuyang, Beijing, Yangjiang, Guiyang, Huaihua
2024-08-22
Recruiting
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
NCT06532812Breast Cancer, Breast Carcinoma, Breast Cancer Metastatic, Breast Cancer Triple Negative
Essen Biotech
Phase 1/2
85
Beijing
2024-08-22
Recruiting
Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
NCT07399210Lung Cancer (Diagnosis), Fragmentomics
Baohui Han
Observational
240
Shanghai
2024-08-21
Recruiting
Large Segmentation Radiotherapy ยฑ Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer
NCT06660628Breast Cancer
Peking Union Medical College Hospital
Not applicable
348
Beijing
2024-08-21
Not yet open
Priority-Matching Correction Technique in Degenerative Lumbar Scoliosis
NCT06470165Degenerative Lumbar Disease, Scoliosis, Degenerative Scoliosis
Xuanwu Hospital, Beijing
Not applicable
200
Beijing
2024-08-21
Active, closed
MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma
NCT06640153Gastric Cancer, Gastroesophageal Junction Cancer
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-08-21
Recruiting
177Lu-JH04 in Patients with FAP-Positive Tumors
NCT06636617Patients with Advanced Metastatic FAP-Positive Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
9
Fuzhou
2024-08-21
Recruiting
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
NCT06451861Acute Myeloid Leukemia
Guangdong Provincial People's Hospital
Phase 2
240
Dongguan, Foshan, Guangzhou, Shenzhen, Zhanjiang, Zhuhai, Haikou
2024-08-21
Active, closed
Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
NCT06449027Breast Cancer Subjects
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
211
Shanghai
2024-08-21
Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT06290141Chronic Inflammatory Demyelinating Polyneuropathy
Sanofi
Phase 3
160
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jiazhuang, Jinan
2024-08-21
Active, closed
Clinical Effectiveness of Non-contact Heart Rate and Respiratory Rate Monitoring System
NCT06573203Sleep, Infant๏ผŒnewborn, Vital Signs
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
70
Hangzhou
2024-08-21
Recruiting
Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS
NCT06587698Polycystic Ovarian Syndrome
Peking University Third Hospital
Not applicable
300
Beijing
2024-08-21
Not yet open
To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer
NCT06561646Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
60
Nanjing
2024-08-21
Recruiting
ADSCs Therapy in Patients With CTD-ILD
NCT06574581Connective Tissue Diseases, Interstitial Lung Disease
China Medical University Hospital
Phase 1/2
16
2024-08-20
Recruiting
A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer
NCT07096128mCRPC
Jinming Zhang
Phase 1
36
Beijing
2024-08-20
Recruiting
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
NCT06551207Metastatic Colorectal Cancer
Liu Huang
Not applicable
80
Wuhan
2024-08-20
Recruiting
Effectiveness of Gut Microbiota-targeted Diatery Intervention Among Older People Living With HIV
NCT06560840Hiv, Atherosclerosis, Diet, Healthy
Fudan University
Not applicable
110
Shenzhen
2024-08-20
Recruiting
Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization
NCT06429891Solid Tumor
Hua Zhu
Not applicable
50
Beijing
2024-08-20
Recruiting
Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients
NCT06622798Exploring the Correlation of HRD Score Pairs with the Prognosis of Chinese Ovarian Cancer Patients and the Outcome of Maintenance Therapy with PARPi
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
470
Guangzhou
2024-08-20
Recruiting
Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)
NCT06534723Alzheimer's Dementia
Sichuan Jishengtang Pharmaceutical Co., Ltd.
Phase 3
570
Fuzhou
2024-08-20
Recruiting
Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis๏ผŒan Exploratory, Single-Arm, Multicenter Phase II Clinical Study
NCT06538896Triple-negative Breast Cancer, Bone Metastases
Zhejiang Cancer Hospital
Phase 2
20
Hangzhou
2024-08-20
Recruiting
Treatment of Mandibular Bone Cyst by Navigation and Endoscopy
NCT06567535Jaw Cysts
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
122
Guangzhou
2024-08-20
Recruiting
Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)
NCT06519565Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
6
Wuhan
2024-08-20
Recruiting
Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
NCT06891157Chidamide, R-CHOP Chemotherapy, DLBCL - Diffuse Large B Cell Lymphoma, Double-expressor Lymphoma (DEL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
148
Nanjing
2024-08-20
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
NCT06538012Lung Cancer, Lung Cancer Metastatic, Lung Cancer, Non-small Cell, Lung Cancer Recurrent
Essen Biotech
Phase 1/2
85
Beijing
2024-08-20
Recruiting
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
NCT07711171Type 2 Diabetes Mellitus, Cognitive Impairment
Fudan University
Phase 4
60
Shanghai
2024-08-19
Not yet open
Effects of Napping in Pregnant Women With Sleep Disturbances on Offspring Neurodevelopment
NCT06514833Sleep
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
80
Shanghai
2024-08-19
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
NCT06461897Atopic Dermatitis
AbbVie
Phase 3
675
Beijing, Yuzhong District, Xiamen, Shenzhen, Zhengzhou, Changsha, Dalian, Chengdu
2024-08-19
Recruiting
Genetically Modified T Cells Treating Malignant Tumors
NCT06515626Solid Tumor
Yi Zhang
Phase EARLY_PHASE1
100
Zhengzhou
2024-08-18
Recruiting
Trial of JMKX003801 in Healthy Participants
NCT06549309Healthy
Jemincare
Phase 1
70
Shanghai
2024-08-17
By invitation
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
NCT06350331Venous Thromboembolism, Digital Health, Health Education
Navy General Hospital, Beijing
Not applicable
256
Beijing
2024-08-17
Recruiting
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
NCT06685276Colorectal Cancer Metastatic
Dai, Guanghai
Phase 2
46
Beijing
2024-08-16
Recruiting
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
NCT07122414Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Active, closed
Novel Lenses for Myopia Progression Trial
NCT06563700Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
342
Shanghai
2024-08-16
Active, closed
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
NCT06632106Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitor, Immune Checkpoint Inhibitors, Hepatocellular Carcinoma (HCC)
First Hospital of China Medical University
Observational
97
Shenyang
2024-08-16
Active, closed
Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers
NCT06531512Diabetic Foot Ulcer
Oneness Biotech Co., Ltd.
Phase 2/3
120
Jiangmen, Luoyang, Suzhou, Zhenjiang, Shenyang, Xi'an, Hangzhou, Guangzhou
2024-08-16
By invitation
Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer
NCT06962449Non-Small-Cell Lung Cancer, Non-Small-Cell Lung Cancer Stage IV
Shanghai Chest Hospital
Observational
500
Shanghai
2024-08-16
Recruiting
Evaluating the Feasibility of Bioresorbable Iron-Based Covered Stent: A Clinical Trial
NCT07316855Coarctation of the Aorta
Shubo Song
Not applicable
10
Zhengzhou
2024-08-16
Recruiting
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
NCT06504732Stomach Neoplasms, Solid Tumor
SUNHO๏ผˆChina๏ผ‰BioPharmaceutical CO., Ltd.
Phase 2/3
574
Harbin, Shenyang
2024-08-15
By invitation
Evaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease
NCT06518681Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Regurgitation
Suzhou Hearthill Medical Technology Co.,LTD
Not applicable
10
Shanghai
2024-08-15
Not yet open
OXiris for Abdominal SEptic Shock (OASES Study)
NCT06504316Septic Shock, Abdominal Sepsis, Multi Organ Failure, Blood Purification
RenJi Hospital
Not applicable
192
Shanghai
2024-08-15
Recruiting
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
NCT06479356Non-Hodgkin Lymphoma, Large B-cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 2
12
Tianjin
2024-08-15
Active, closed
Acupuncture for Enhancing Immunotherapy in Advanced NSCLC๏ผša Pilot Study
NCT06461338Non-small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma
Guangzhou University of Traditional Chinese Medicine
Not applicable
60
Guangzhou, Nanjing
2024-08-15
Recruiting
Electroencephalography in the Management of Neuroelectric Stimulation in Patients With Severe Traumatic Brain Injuries
NCT06571032Brain Injuries
RenJi Hospital
Observational
50
Shanghai
2024-08-15
Recruiting
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
NCT06554626Precursor B-Cell Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University
Phase 2
20
Hangzhou
2024-08-15
Not yet open
Clinical Study of FB1001 in Patients
NCT06506305Optic Neuropathy, NAION - Non-Arteritic Ischemic Optic Neuropathy, APAC - Acute Primary Angle Closure, Glaucoma, Angle-Closure
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 1
59
Shanghai
2024-08-15
Recruiting
Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)
NCT06561399Hepatocellular Carcinoma Non-resectable
Fujian Provincial Hospital
Observational
28
Fuzhou
2024-08-15
Recruiting
Phase โ…ก Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer
NCT06708858Advanced Biliary Tract Cancer
Dai, Guanghai
Phase 2
35
Beijing
2024-08-15
Recruiting
A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors
NCT07110883Advanced Solid Tumor
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1
400
Harbin, Shanghai
2024-08-15
Not yet open
Research of the Application of Artificial Intelligence Model "PANDA"
NCT06528223Pancreatic Cancer
Zhejiang University
Not applicable
200,000
Hangzhou
2024-08-15
Recruiting
A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.
NCT06561555Mammary or Extramammary Paget's Disease
Fudan University
Phase 2
36
Shanghai
2024-08-15
Recruiting
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479Chemotherapy-induced Neutropenia
Anhui Provincial Hospital
Observational
318
Hefei
2024-08-15
Active, closed
Medication Adherence to Phone-supervised Pancreatic Enzyme Replacement Therapy
NCT06581653Chronic Pancreatitis, Pancreatic Exocrine Insufficiency
Changhai Hospital
Not applicable
204
Shanghai
2024-08-15
Not yet open
Effect of Aerobic Interval Training on Atrial Fibrillation Burden
NCT06491329Atrial Fibrillation, Cardiac Rehabilitation
Navy General Hospital, Beijing
Not applicable
156
Beijing
2024-08-15
Recruiting
Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer
NCT07016724Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2
208
Zhengzhou
2024-08-15
Not yet open
The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus
NCT06546436Autoimmune Type 1 Diabetes Mellitus(T1DM)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase EARLY_PHASE1
12
Nanjing
2024-08-15
By invitation
Application of FAPI Visualization in the Assessment of Right Ventricular Dysfunction Due to Volume Overload
NCT06663566Right Heart Insufficiency, Tricuspid Regurgitation
Beijing Anzhen Hospital
Observational
90
Beijing
2024-08-15
Recruiting
Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors
NCT06553365Nerve Sheath Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
30
Beijing
2024-08-15
Recruiting
MRSI Evaluation for Minor Stroke With Large Vessel Occlusion
NCT06457217Acute Ischemic Stroke
Shanghai 6th People's Hospital
Observational
75
Shanghai
2024-08-15
Recruiting
One-Month DAPT in CABG Patients
NCT05997693Chronic Coronary Disease
Weill Medical College of Cornell University
Phase 3
700
Shanghai, Changchun, Beijing
2024-08-15
By invitation
Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive Stroke
NCT06551727Stroke, Ischemic
Ruijin Hospital
Not applicable
70
Shanghai
2024-08-15
Recruiting
Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC
NCT06467617Non Small Cell Lung Cancer
Beijing Chest Hospital, Capital Medical University
Phase 2
35
Beijing
2024-08-14
Recruiting
Value of Bronchoalveolar Lavage with Acetylcysteine in the Treatment of Bronchiectasis.
NCT06726356Bronchiectasis with Acute Exacerbation
First Affiliated Hospital of Ningbo University
Not applicable
180
Ningbo
2024-08-14
Active, closed
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
NCT06247995Breast Cancer
Novartis Pharmaceuticals
Phase 1/2
20
Tianjin
2024-08-14
Active, closed
Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
NCT06492915Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd.
Phase 2
42
Shanghai
2024-08-13
Recruiting
Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)
NCT06656624Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
190
Nanjing
2024-08-13
Recruiting
Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
NCT06553053Crohn's Disease Relapse, Inflammatory Bowel Diseases
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
106
Shanghai
2024-08-13
Recruiting
Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.
NCT07188441GCT, Germ Cell Tumor, Central Malignant Germ Cell Tumor
Chengcheng Guo
Phase 2
40
Guangzhou
2024-08-13
Recruiting
Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome
NCT06545721Polycystic Ovary Syndrome
Peking Union Medical College Hospital
Not applicable
425
Beijing
2024-08-13
Recruiting
MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
NCT06840665Locally Advanced Rectal Cancer
Fudan University
Phase 2
46
Shanghai
2024-08-13
Active, closed
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT06508658Diffuse Large B-Cell Lymphoma
Genmab
Phase 3
379
Beijing, Fuzhou, Xiamen, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan
2024-08-13
Recruiting
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
NCT06529250AML
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
148
Tianjin
2024-08-13
Recruiting
Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
NCT06553898Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
18
Hangzhou
2024-08-13
Recruiting
Bolt CSP-M Holter Study
NCT06540521Heart Failure, Bradycardia
Medtronic Cardiac Rhythm and Heart Failure
Observational
75
Shanghai, Hangzhou
2024-08-13
Recruiting
Hypofractionated Radiotherapy
NCT06740955Glioblastoma
The First Hospital of Jilin University
Not applicable
420
Changchun
2024-08-13
Recruiting
The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC
NCT06727162Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
100
Guangzhou
2024-08-13
Recruiting
Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)
NCT06592170Lymphoma
The First Hospital of Jilin University
Phase 1/2
35
Changchun
2024-08-13
Recruiting
Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis
NCT06503692Arteriovenous Graft Stenosis
DK Medical Technology (Suzhou) Co., Ltd.
Not applicable
140
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Shanghai
2024-08-13
Active, closed
Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis
NCT06700421Unresectable Locally Advanced Non-small Cell Lung Cancer
Wei Zhou
Phase 2
32
Chongqing
2024-08-13
Recruiting
A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
NCT06615193Advanced Solid Tumors, Refractory Lymphoma, Relapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
111
Zhengzhou, Suzhou, Xuzhou, Nanchang, Jinan, Hangzhou, Tianjing
2024-08-12
Not yet open
Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy
NCT06568445Bronchial Asthma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
90
Shanghai
2024-08-12
Recruiting
Accuracy of 68Ga-Pentixafor PET/CT for Subtypting Diagnosis in Patients With Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
NCT06635993Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
Qifu Li
Observational
97
Chongqing
2024-08-12
Recruiting
Clinical Research Protocol of Ferumoxytol for Magnetic Resonance Enhancement Imaging in Patients With Atherosclerosis.
NCT06551805Atherosclerosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
100
Nanjing
2024-08-12
Recruiting
A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients
NCT06555068Advanced Unresectable or Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
528
Shanghai
2024-08-12
Recruiting
A Real World Study of Sacituzumab Govitecan
NCT06966141Breast Cancer Metastatic, Treatment Outcome
Fudan University
Observational
100
Shanghai
2024-08-12
Recruiting
A Comparing Study Between SJ04 and Ovidrelยฎ in Healthy Subjects
NCT06599528Assisted Reproductive Technology, Female Infertility
Suzhou Centergene Pharmaceuticals Co.,Ltd.
Phase 1
48
Suzhou
2024-08-12
Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
NCT06467357Biliary Tract Cancer
AstraZeneca
Phase 3
620
Beijing, Bengbu, Changchun, Changde, Changsha, Chengdu, Chongqing, Fuzhou
2024-08-12
Recruiting
Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
NCT06519526Relapsed/Refractory Peripheral T Cell Lymphoma
Fudan University
Phase 2
25
Shanghai
2024-08-12
Rows per page Showing 11801–11900 of 19052
Previous 117 118 119 120 121 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=119

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.